Nebraska Medical Center — Omaha, Nebraska

Public research footprint of Nebraska Medical Center, compiled from the ClinicalTrials.gov public registry.

1,715

Registered studies

520

Active

255

Recruiting now

938

Completed

206

Stopped or withdrawn

Most-studied conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Lung Non-Small Cell Squamous Carcinoma · Locally Advanced Malignant Solid Neoplasm · Recurrent Endometrial Carcinoma

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nebraska Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.